112 related articles for article (PubMed ID: 3706371)
1. Biclonal and hypodiploid multiple myeloma.
Smith L; Barlogie B; Alexanian R
Am J Med; 1986 May; 80(5):841-3. PubMed ID: 3706371
[TBL] [Abstract][Full Text] [Related]
2. DNA and RNA flow cytometric study in multiple myeloma. Clinical correlations.
Tafuri A; Meyers J; Lee BJ; Andreeff M
Cancer; 1991 Jan; 67(2):449-54. PubMed ID: 1985738
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of tumor cell DNA and RNA content in multiple myeloma.
Barlogie B; Alexanian R; Dixon D; Smith L; Smallwood L; Delasalle K
Blood; 1985 Aug; 66(2):338-41. PubMed ID: 2410065
[TBL] [Abstract][Full Text] [Related]
4. High-dose glucocorticoid treatment of resistant myeloma.
Alexanian R; Barlogie B; Dixon D
Ann Intern Med; 1986 Jul; 105(1):8-11. PubMed ID: 3717812
[TBL] [Abstract][Full Text] [Related]
5. DNA content of human myeloma cells.
Lewensohn R; Tribukait B; Hansson J
Eur J Cancer Clin Oncol; 1983 Jan; 19(1):59-63. PubMed ID: 6682777
[TBL] [Abstract][Full Text] [Related]
6. Is flow cytometric DNA content hypodiploidy prognostic in multiple myeloma?
Greipp PR; Trendle MC; Leong T; Oken MM; Kay NE; Van Ness B; Kyle RA
Leuk Lymphoma; 1999 Sep; 35(1-2):83-9. PubMed ID: 10512165
[TBL] [Abstract][Full Text] [Related]
7. A new staging system for multiple myeloma based on the number of S-phase plasma cells.
San Miguel JF; García-Sanz R; González M; Moro MJ; Hernández JM; Ortega F; Borrego D; Carnero M; Casanova F; Jiménez R
Blood; 1995 Jan; 85(2):448-55. PubMed ID: 7811998
[TBL] [Abstract][Full Text] [Related]
8. Marrow cytometry and prognosis in myeloma.
Barlogie B; Alexanian R; Gehan EA; Smallwood L; Smith T; Drewinko B
J Clin Invest; 1983 Sep; 72(3):853-61. PubMed ID: 6193144
[TBL] [Abstract][Full Text] [Related]
9. Plasma cell DNA content in multiple myeloma and related paraproteinemic disorders. Relationship with clinical and cytokinetic features.
Montecucco C; Riccardi A; Merlini G; Mazzini G; Giordano P; Danova M; Ascari E
Eur J Cancer Clin Oncol; 1984 Jan; 20(1):81-90. PubMed ID: 6537918
[TBL] [Abstract][Full Text] [Related]
10. Characterization of hematologic malignancies by flow cytometry.
Barlogie B; Latreille J; Freireich EJ; Fu CT; Mellard D; Meistrich M; Andreeff M
Blood Cells; 1980; 6(4):719-44. PubMed ID: 7008871
[TBL] [Abstract][Full Text] [Related]
11. Bence-Jones myeloma.
Roy DN; Mitra S; Biswas TK; Dasbiswas A; Das D; Chatterjee B; Dutta SK
J Indian Med Assoc; 1988 Mar; 86(3):70-2. PubMed ID: 3397569
[No Abstract] [Full Text] [Related]
12. Multiple myeloma in younger age.
Akhtar K; Laghari NA; Haq AU; Anees M; Rehman SU; Alam MI
J Coll Physicians Surg Pak; 2009 Jan; 19(1):62-3. PubMed ID: 19149986
[TBL] [Abstract][Full Text] [Related]
13. [Prognosis of multiple myeloma].
Morell A; Skvaril F; Rüst HP; Spengler GA; Brunner K; Barandun S
Schweiz Med Wochenschr; 1970 Nov; 100(46):1990-2. PubMed ID: 5507847
[No Abstract] [Full Text] [Related]
14. Effective treatment of advanced multiple myeloma refractory to alkylating agents.
Barlogie B; Smith L; Alexanian R
N Engl J Med; 1984 May; 310(21):1353-6. PubMed ID: 6546971
[TBL] [Abstract][Full Text] [Related]
15. Nonsecretory myeloma. Immunofluorescent demonstration of paraprotein within bone marrow plasma cells.
Arend WP; Adamson JW
Cancer; 1974 Mar; 33(3):721-8. PubMed ID: 4131359
[No Abstract] [Full Text] [Related]
16. Hyperdiploid myeloma cell as an indicator of poor prognosis and drug refractoriness.
Hata H; Matsuzaki H; Yoshida M; Sonoki T; Kuribayashi N; Nagasaki A; Kimura T; Harada N; Takatsuki K
Int J Hematol; 1997 Aug; 66(2):219-26. PubMed ID: 9277053
[TBL] [Abstract][Full Text] [Related]
17. [A case of Bence-Jones protein-lambda positive multiple myeloma complicated by abnormal plasma cells in pleural effusion].
Shirai T; Hashizume I; Kasamatsu N; Nakamura A; Yamatani H; Hanzawa S; Momiki S; Sasaki K; Yano K; Ozawa T
Nihon Kokyuki Gakkai Zasshi; 1998 Feb; 36(2):176-81. PubMed ID: 9617146
[TBL] [Abstract][Full Text] [Related]
18. The flow-cytometric DNA content of the plasma cells of patients with multiple myeloma is a prognostic factor: a single institution experience.
López-Otero A; Ruiz-Delgado GJ; Hernández-Arizpe A; Ruiz-Argüelles A; Ruiz-Argüelles GJ
Hematology; 2010 Dec; 15(6):378-81. PubMed ID: 21114899
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis of multiple myeloma by demonstrating plasma cells in bronchoalveolar lavage].
Burkhardt O; Dickgreber NJ; Bühling F; Waldburg N; Merker HJ; Welte T
Dtsch Med Wochenschr; 2003 Sep; 128(38):1951-4. PubMed ID: 14502447
[TBL] [Abstract][Full Text] [Related]
20. An unusual case of non secretory multiple myeloma with intracellular lambda chains.
Pelosio A; Di Biagio T; Franchi F
Haematologica; 1981 Apr; 66(2):223-7. PubMed ID: 6792000
[No Abstract] [Full Text] [Related]
[Next] [New Search]
